These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11756961)

  • 1. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.
    Calamia KT; Balabanova M; Perniciaro C; Walsh JS
    J Am Acad Dermatol; 2002 Jan; 46(1):133-7. PubMed ID: 11756961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
    Biedermann T; Flaig MJ; Sander CA
    J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy.
    Chang D; Patel RM
    Cutis; 2012 Oct; 90(4):179, 181-2. PubMed ID: 23259203
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated.
    Callen JP
    Arch Dermatol; 2006 Nov; 142(11):1481-2. PubMed ID: 17116840
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasculitis related to antineutrophil cytoplasmic antibodies to myelo peroxidase in a patient heterozygous for factor V Leiden mutation].
    Spuls PI; Nanninga PB; Mekkes JR
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2430-1. PubMed ID: 11232541
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical presentation of livedo racemosa in a factor V Leiden heterozygous positive patient with Pseudomonas aeruginosa urosepsis.
    Johnston J; Noakes R; Davidson K
    Australas J Dermatol; 2017 Aug; 58(3):e144-e147. PubMed ID: 27858977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous factor V Leiden mutation in a patient with traumatic leg ulceration.
    McLoone N; Lee B; Anderson J; McKenna K
    Clin Exp Dermatol; 2003 Nov; 28(6):608-9. PubMed ID: 14616826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedo reticularis and livedoid vasculitis responding to PUVA therapy.
    Choi HJ; Hann SK
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):204-7. PubMed ID: 10025746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T
    Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2009 Dec; 34(8):e811-3. PubMed ID: 19793098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.
    Dhanjal S; Saso A; Eleftheriou D; Laurent S
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.